Joseph C Papa is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 1.43 Million shares of BHC, which is worth approximately $11.4 Million. The most recent transaction as insider was on May 10, 2022, when has been sold 33,714 shares (Common Shares, no par value) at a price of $9.4 per share, resulting in proceeds of $316,912. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.43M
0% 3M change
0% 12M change
Total Value Held $11.4 Million

JOSEPH C PAPA Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2022
SELL
Payment of exercise price or tax liability
$316,912 $9.4 p/Share
33,714 Reduced 2.31%
1,427,568 Common Shares, no par ...
May 10 2022
BUY
Exercise of conversion of derivative security
-
366,130 Added 20.04%
1,461,282 Common Shares, no par ...
Mar 03 2022
SELL
Payment of exercise price or tax liability
$298,501 $23.61 p/Share
12,643 Reduced 1.14%
1,095,152 Common Shares, no par ...
Feb 28 2022
SELL
Payment of exercise price or tax liability
$123,067 $24.06 p/Share
5,115 Reduced 0.46%
1,107,795 Common Shares, no par ...
Feb 27 2022
SELL
Payment of exercise price or tax liability
$2,765,113 $24.35 p/Share
113,557 Reduced 9.26%
1,112,910 Common Shares, no par ...
Feb 27 2022
BUY
Exercise of conversion of derivative security
-
208,231 Added 14.38%
1,239,650 Common Shares, no par ...
Feb 26 2022
SELL
Payment of exercise price or tax liability
$321,006 $24.35 p/Share
13,183 Reduced 1.16%
1,126,116 Common Shares, no par ...
Sep 14 2021
SELL
Payment of exercise price or tax liability
$143,587 $28.66 p/Share
5,010 Reduced 0.48%
1,031,419 Common Shares, no par ...
Sep 13 2021
SELL
Payment of exercise price or tax liability
$103,595 $29.19 p/Share
3,549 Reduced 0.34%
1,036,429 Common Shares, no par ...
Mar 10 2021
SELL
Payment of exercise price or tax liability
$7,622,269 $32.97 p/Share
231,188 Reduced 18.19%
1,039,978 Common Shares, no par ...
Mar 08 2021
BUY
Grant, award, or other acquisition
-
108,254 Added 7.85%
1,271,166 Common Shares, no par ...
Mar 08 2021
BUY
Exercise of conversion of derivative security
-
317,089 Added 21.42%
1,162,912 Common Shares, no par ...
Mar 03 2021
BUY
Grant, award, or other acquisition
-
74,150 Added 8.06%
845,823 Common Shares, no par ...
Mar 01 2021
SELL
Payment of exercise price or tax liability
$885,793 $31.42 p/Share
28,192 Reduced 3.52%
771,673 Common Shares, no par ...

Also insider at

RXDX
Prometheus Biosciences, Inc. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
CADL
Candel Therapeutics, Inc. Healthcare
EBS
Emergent BioSolutions Inc. Healthcare
MIST
Milestone Pharmaceuticals Inc. Healthcare
JCP

Joseph C Papa

Director
Needham, MA

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC